Allowing men to access test results online provides just as good support while saving the NHS money.
We publish new best practice guidelines on active surveillance, as NICE advise it should be offered to men with low risk localised prostate cancer.
BLOG: Last year we asked supporters to sign a petition for better access to mpMRI scans in Wales. Our Policy Manager, Tim Windle, gives an update on the progress made so far.
After years of us campaigning, Northern Ireland's Department of Health says it will now develop a strategy for the only Home Nation without one – and we're making sure prostate cancer is a key part of it.
BLOG: This week, the Government unveiled its new 10-year plan for the NHS in England. We scrutinised all 136 pages of it to find out what impacts it could have for men being treated or diagnosed for prostate cancer, and how it could help – or hinder – our own plans.
The National Institute for Health and Care Excellence has recommended pre-biopsy mpMRI scans and a host of other improvements to diagnosis and treatments for prostate cancer become standard NHS practice across the UK. While we back the proposals, we're calling for enough scanners and trained staff to deliver them.
Belfast City Hospital's £1.5 million robot is set to operate on up to 100 men a year, ending years of men having to travel to England for the procedure and no prostate surgery at all in North Ireland since 2016. We get the reaction from two of our volunteers who have helped us campaign for this welcome breakthrough.
Voted for by her colleagues, patients and their families, Sandie Jones scoops our inaugural award for her extraordinary 20-year career caring for men – from biopsy to post-treatment support. We spoke to her and one of her grateful patients, and find out why we're campaigning for more nurses like Sandie across the UK.
BLOG: Our policy manager, Tim Windle, reflects on a missed opportunity and outlines what NHS England and the devolved nations must do now to improve the future for men with prostate cancer.
The latest results from the STAMPEDE trial have shown immediate radiotherapy with standard hormone therapy could increase the survival of thousands of men diagnosed with advanced prostate cancer that hasn't spread too widely. We're now calling for the treatment to be offered to these men as standard on the NHS.